{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:05Z","timestamp":1777561205097,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002660","name":"Islamic Azad University","doi-asserted-by":"publisher","award":["162426721"],"award-info":[{"award-number":["162426721"]}],"id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.micpath.2023.106033","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T07:14:51Z","timestamp":1676877291000},"page":"106033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A chimeric vaccine targeting Pseudomonas aeruginosa virulence factors protects mice against lethal infection"],"prefix":"10.1016","volume":"178","author":[{"given":"Fatemeh","family":"Korpi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Irajian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Forouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher","family":"Mohammadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2023.106033_bib1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.burns.2015.05.007","article-title":"Microbiology and antibiotic resistance in severe burns patients: a 5 year review in an adult burns unit","volume":"41","author":"Bahemia","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.micpath.2023.106033_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.burns.2009.10.013","article-title":"Prevalence of multidrug-resistant organisms recovered at a military burn center","volume":"36","author":"Keen","year":"2010","journal-title":"Burns"},{"key":"10.1016\/j.micpath.2023.106033_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12668-019-00658-4","article-title":"World health organization report: current crisis of antibiotic resistance","volume":"9","author":"Talebi Bezmin Abadi","year":"2019","journal-title":"BioNanoScience"},{"key":"10.1016\/j.micpath.2023.106033_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103697","article-title":"A trivalent vaccine consisting of \"flagellin A+B and pilin\" protects against Pseudomonas aeruginosa infection in a murine burn model","volume":"138","author":"Hashemi","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2023.106033_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molimm.2019.10.005","article-title":"Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models","volume":"116","author":"Ranjbar","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/sur.2018.233","article-title":"Progress toward the elusive Pseudomonas aeruginosa vaccine","volume":"19","author":"Merakou","year":"2018","journal-title":"Surg. Infect."},{"key":"10.1016\/j.micpath.2023.106033_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122617","article-title":"Understanding Pseudomonas aeruginosa-host interactions: the ongoing quest for an efficacious vaccine","volume":"9","author":"Sainz-Mejias","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2023.106033_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.biologicals.2016.06.009","article-title":"Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection","volume":"44","author":"Banadkoki","year":"2016","journal-title":"Biologicals : J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.micpath.2023.106033_bib9","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.28271","article-title":"Cloning, expression, and purification of Pseudomonas aeruginosa flagellin, and characterization of the elicited anti-flagellin antibody","volume":"18","author":"Behrouz","year":"2016","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.micpath.2023.106033_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.burns.2016.03.015","article-title":"Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: protective efficacy in a murine burn wound sepsis model","author":"Behrouz","year":"2016","journal-title":"Burns\u202f: journal of the International Society for Burn Injuries"},{"key":"10.1016\/j.micpath.2023.106033_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/IAI.00850-10","article-title":"Full virulence of Pseudomonas aeruginosa requires OprF","volume":"79","author":"Fito-Boncompte","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib12","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.4161\/21645515.2014.971641","article-title":"Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa","volume":"10","author":"Sawa","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2023.106033_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fmicb.2015.00630","article-title":"The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level","volume":"6","author":"Bouffartigues","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2023.106033_bib14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.1112422","article-title":"Recognition of host immune activation by Pseudomonas aeruginosa","volume":"309","author":"Wu","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micpath.2023.106033_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tim.2005.12.002","article-title":"Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals","volume":"14","author":"Wagner","year":"2006","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2023.106033_bib16","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/IAI.73.7.4395-4398.2005","article-title":"Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections","volume":"73","author":"Arora","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/iai.38.3.1296-1298.1982","article-title":"Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model","volume":"38","author":"Montie","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib18","first-page":"79","article-title":"Selection of non-flagellated and non-piliated mutants from Pseudomonas aeruginosa strain TPB-1","volume":"60","author":"Sato","year":"1987","journal-title":"Kitasato Arch. Exp. Med."},{"key":"10.1016\/j.micpath.2023.106033_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2180-10-9","article-title":"Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization","volume":"10","author":"Peluso","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2023.106033_bib20","first-page":"761","article-title":"Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization","volume":"371B","author":"Cripps","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.micpath.2023.106033_bib21","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/IAI.69.5.3510-3515.2001","article-title":"Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa","volume":"69","author":"Price","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib22","doi-asserted-by":"crossref","first-page":"13801","DOI":"10.1128\/JVI.01246-07","article-title":"Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF","volume":"81","author":"Worgall","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2023.106033_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.vaccine.2003.11.029","article-title":"Recombinant OprF\u2013OprI as a vaccine against Pseudomonas aeruginosa infections","volume":"22","author":"Baumann","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2023.106033_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2016.04.002","article-title":"Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model","volume":"176","author":"Korpi","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2023.106033_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molimm.2016.04.008","article-title":"Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model","volume":"74","author":"Laghaei","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biologicals.2016.10.007","article-title":"Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds","volume":"45","author":"Saffari","year":"2017","journal-title":"Biologicals : J. Int. Assoc. Buddhist Stud."},{"key":"10.1016\/j.micpath.2023.106033_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2016.12.005","article-title":"Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models","volume":"46","author":"Ahmadi","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.micpath.2023.106033_bib28","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1016\/j.vaccine.2009.08.080","article-title":"Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa","volume":"27","author":"Weimer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2023.106033_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1099\/jmm.0.000174","article-title":"Pseudomonas aeruginosa flagellin as an adjuvant: superiority of a conjugated form of flagellin versus a mixture with a human immunodeficiency virus type 1 vaccine candidate in the induction of immune responses","volume":"64","author":"Delavari","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2023.106033_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2017\/5689709","article-title":"Immunization with bivalent flagellin protects mice against fatal Pseudomonas aeruginosa pneumonia","volume":"2017","author":"Behrouz","year":"2017","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.micpath.2023.106033_bib31","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin\u2014a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.micpath.2023.106033_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni1011","article-title":"Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility","volume":"4","author":"Smith","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib33","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1074\/jbc.M307759200","article-title":"Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro","volume":"279","author":"Murthy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2023.106033_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4049\/jimmunol.181.1.586","article-title":"Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin","volume":"181","author":"Ramphal","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CVI.00669-13","article-title":"Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines","volume":"21","author":"Gupta","year":"2014","journal-title":"Clin. Vaccine Immunol. : CVI"},{"key":"10.1016\/j.micpath.2023.106033_bib36","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.micpath.2023.106033_bib37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10529-009-0026-1","article-title":"Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa","volume":"31","author":"Goudarzi","year":"2009","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.micpath.2023.106033_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/rccm.201202-0182OC","article-title":"Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia","volume":"186","author":"Wu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2023.106033_bib39","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.181.7.4965","article-title":"IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa","volume":"181","author":"Priebe","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib40","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1128\/IAI.72.12.7012-7021.2004","article-title":"Oral vaccination of BALB\/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model","volume":"72","author":"DiGiandomenico","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2023.106033_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.vaccine.2003.11.028","article-title":"Pseudomonas immunotherapy: a historical overview","volume":"22","author":"Holder","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2023.106033_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12864-016-2364-4","article-title":"Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species","volume":"17","author":"Mosquera-Rendon","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.micpath.2023.106033_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1348-0421.1988.tb01372.x","article-title":"Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection","volume":"32","author":"Sato","year":"1988","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib45","article-title":"Active immunization with recombinant PilA protein protects against Pseudomonas aeruginosa infection in a mouse burn wound model","author":"Korpi","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2023.106033_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037459","article-title":"Genetic and phenotypic characterization of a Pseudomonas aeruginosa population with high frequency of genomic islands","volume":"7","author":"Morales-Espinosa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106033_bib47","first-page":"125","article-title":"Molecular detection of virulence genes as markers in Pseudomonas aeruginosa isolated from urinary tract infections","volume":"5","author":"Sabharwal","year":"2014","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.micpath.2023.106033_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2016.07.013","article-title":"Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran","volume":"99","author":"Faraji","year":"2016","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2023.106033_bib49","first-page":"189","article-title":"The role of Langerhans cells in Pseudomonas aeruginosa infection","volume":"43","author":"Hazlett","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.micpath.2023.106033_bib50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1172\/JCI200111564","article-title":"Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity","volume":"108","author":"Kikuchi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micpath.2023.106033_bib51","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.69.7.4521-4527.2001","article-title":"Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells","volume":"69","author":"Worgall","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib52","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","article-title":"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response","volume":"172","author":"Didierlaurent","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib53","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.4049\/jimmunol.170.10.5165","article-title":"The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells","volume":"170","author":"Means","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib54","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.200425719","article-title":"Decision criteria for resolving isotype switching conflicts by B cells","volume":"35","author":"Deenick","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085623","article-title":"Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10+ IL-12- neutrophil polarization","volume":"9","author":"Neely","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106033_bib56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/14760584.2014.890053","article-title":"Vaccines for Pseudomonas aeruginosa: a long and winding road","volume":"13","author":"Priebe","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2023.106033_bib57","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/IAI.00806-09","article-title":"Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines","volume":"78","author":"Campodonico","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2012.11.002","article-title":"Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli","volume":"54","author":"Karam","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib60","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/IAI.00157-11","article-title":"Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice","volume":"79","author":"Campodonico","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106033_bib61","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fimmu.2019.00781","article-title":"Rational design of a chimeric derivative of PcrV as a subunit vaccine against Pseudomonas aeruginosa","volume":"10","author":"Wan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2023.106033_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/2049-632X.12033","article-title":"Pseudomonas aeruginosa: new insights into pathogenesis and host defenses","volume":"67","author":"Gellatly","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.micpath.2023.106033_bib63","first-page":"1983","article-title":"Pseudomonas aeruginosa PcrV and psl, the molecular targets of bispecific antibody MEDI3902, are conserved among diverse global clinical isolates","volume":"218","author":"Tabor","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106033_bib64","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1172\/JCI89652","article-title":"Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature","volume":"127","author":"Thanabalasuriar","year":"2017","journal-title":"J. Clin. Invest."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:30:21Z","timestamp":1736404221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":64,"alternative-id":["S0882401023000669"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106033","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chimeric vaccine targeting Pseudomonas aeruginosa virulence factors protects mice against lethal infection","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106033"}}